New antibiotic combo targets Drug-Resistant pneumonia
Disease control
Not yet recruiting
This early-stage study tests a new drug called MP101, given alongside standard antibiotics, for adults with a severe lung infection caused by Pseudomonas aeruginosa bacteria. The main goal is to check if MP101 is safe and tolerable in 18 participants. Researchers will also measur…
Phase: PHASE1 • Sponsor: MicrobiotiX Co., Ltd • Aim: Disease control
Last updated May 26, 2026 10:01 UTC